Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6279073 | 0.89 | CYP1A2 (0.33) | CYP3A4 | |
| SCHEMBL8943789 | 0.84 | ACHE (0.45) | TSHRACHECYP3A4LMNASIGMAR1 | |
| SCHEMBL4893894 | 0.82 | ACHE (0.43) | TSHRACHECYP3A4LMNASIGMAR1 | |
| SCHEMBL7486408 | 0.82 | ACHE (0.43) | TSHRACHECYP3A4LMNASIGMAR1 | |
| SCHEMBL7154196 | 0.78 | ACHE (0.39) | TSHRACHECYP3A4LMNASIGMAR1 | |
| SCHEMBL13929896 | 0.78 | ACHE (0.39) | TSHRACHECYP3A4LMNASIGMAR1 | |
| SCHEMBL13480247 | 0.78 | TSHR (0.42) | TSHRACHECYP3A4LMNASIGMAR1 | |
| SCHEMBL8470149 | 0.78 | TSHR (0.43) | TSHRACHECYP3A4LMNASIGMAR1 | |
| SCHEMBL15247033 | 0.76 | ALDH1A1 (0.46) | TSHRACHECYP3A4LMNASIGMAR1 | |
| SCHEMBL7149189 | 0.76 | TSHR (0.41) | TSHRACHECYP3A4LMNASIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7875748-B2 | Prepared by reaction of tetraphenylcyclopentadienone with 1,4-diethynyl-2,5-dimethoxybenzene; can be used as a core material for an organic electroluminescence element or other optical devices | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2011-01-25 | — | — | US | disclosed |
| US-20090240062-A1 | COMPOUND DERIVED FROM CYCLOPENTADIENONE, PREPARATION METHOD THEREOF AND EL ELEMENT USING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-09-24 | — | — | US | disclosed |
| US-20050067955-A1 | Compound derived from cyclopentadienone, preparation method thereof and EL element using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2005-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090240062-A1 | COMPOUND DERIVED FROM CYCLOPENTADIENONE, PREPARATION METHOD THEREOF AND EL ELEMENT USING THE SAME | ELP1, CYP51A1, ELOVL1 | HDAC8 4560/4885TSHR 4852/4885ACHE 1554/4885 |
| US-20050067955-A1 | Compound derived from cyclopentadienone, preparation method thereof and EL element using the same | ELP1, CYP51A1, ELOVL1 | HDAC8 4560/4885TSHR 4852/4885ACHE 1554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.